On Friday, AIM ImmunoTech Inc (AMEX: AIM) opened lower -11.75% from the last session, before settling in for the closing price of $0.25. Price fluctuations for AIM have ranged from $0.21 to $0.62 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales drop of Healthcare Sector giant was -2.98%. Company’s average yearly earnings per share was noted 42.22% at the time writing. With a float of $58.21 million, this company’s outstanding shares have now reached $63.71 million.
Let’s determine the extent of company efficiency that accounts for 26 employees. In terms of profitability, gross margin is 24.21%, operating margin of -14683.68%, and the pretax margin is -12594.21%.
AIM ImmunoTech Inc (AIM) Insider Activity
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of AIM ImmunoTech Inc is 8.62%, while institutional ownership is 14.08%. The most recent insider transaction that took place on Sep 16 ’24, was worth 1,515. In this transaction CEO & President of this company bought 5,000 shares at a rate of $0.30, taking the stock ownership to the 1,493,042 shares. Before that another transaction happened on Sep 13 ’24, when Company’s CEO & President bought 20,000 for $0.31, making the entire transaction worth $6,160. This insider now owns 1,488,042 shares in total.
AIM ImmunoTech Inc (AIM) Earnings and Forecasts
If we go through the results of last quarter, which was made public on 9/30/2024, the company posted -0.28 earnings per share (EPS) for the quarter, coming under the agreed prediction (set at -0.15) by -0.13. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.09 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 42.22% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 25.00% during the next five years compared to 42.86% growth over the previous five years of trading.
AIM ImmunoTech Inc (AMEX: AIM) Trading Performance Indicators
Check out the current performance indicators for AIM ImmunoTech Inc (AIM). In the past quarter, the stock posted a quick ratio of 0.75. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 66.00.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.47, a number that is poised to hit -0.10 in the next quarter and is forecasted to reach -0.34 in one year’s time.
Technical Analysis of AIM ImmunoTech Inc (AIM)
Looking closely at AIM ImmunoTech Inc (AMEX: AIM), its last 5-days average volume was 0.49 million, which is a jump from its year-to-date volume of 0.26 million. As of the previous 9 days, the stock’s Stochastic %D was 31.40%. Additionally, its Average True Range was 0.02.
During the past 100 days, AIM ImmunoTech Inc’s (AIM) raw stochastic average was set at 5.41%, which indicates a significant increase from 4.42% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 67.66% in the past 14 days, which was lower than the 70.78% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.2657, while its 200-day Moving Average is $0.3624. However, in the short run, AIM ImmunoTech Inc’s stock first resistance to watch stands at $0.2425. Second resistance stands at $0.2619. The third major resistance level sits at $0.2729. If the price goes on to break the first support level at $0.2121, it is likely to go to the next support level at $0.2011. Should the price break the second support level, the third support level stands at $0.1817.
AIM ImmunoTech Inc (AMEX: AIM) Key Stats
There are currently 63,706K shares outstanding in the company with a market cap of 12.54 million. Presently, the company’s annual sales total 200 K according to its annual income of -28,960 K. Last quarter, the company’s sales amounted to 50 K and its income totaled -1,840 K.
